Login
Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

Watchlist

Keep track of companies that you follow and research.

10 Years of Data

Full access to our data with predictions and indicators that we calculate daily.

Screener

Full access to our screener with tons of custom values and customizable email notifications.

XLS Exports

Excel export of financials and screeners you define and save.

Keurig Dr Pepper, Inc KDP

Consumer Defensive — Beverages Non Alcoholic
S&P 500 Member Dividend Champion (5y) Insider Buys (last 12m)
Indexes indicate stock being part of an index ,
Growth Flags show if company had growth for consecutive years ,
Insider Buys alert about insiders buying in the last 12 month

We limit data available in the Overview Report for users who do not have Powerpack

Get access to target analyst prices, predictions, compound annual growth rates and more than four years of historical data.
Register an account and get your Powerpack now or Login

Insider Decisions

Total buys
0.25
Total sells
1.38
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — 1 —
Sell — — 1 — — — — — — — — 2
Insider Ownership
4.45%

Capital & Financial Ratios

Market Cap
42,660.00
Revenue
20,090.00
Net Income
1,495.00
Free Cash Flow
1,985.00
Net Debt
28,427.00
Current Ratio
0.48
Debt/Equity
1.03
P/E ratio
31.27
P/S ratio
2.10
P/B ratio
1.44
Past 5Y EPS Growth
3.57%
This Y EPS Growth
11.83%
Next Y EPS Growth
10.40%
Next 5Y EPS Growth
9.90%
in millions of $

Dividends

Payout Ratio
0.71
Annual Dividend Rate
0.86
Annual Dividend Yield
2.61%
total individual payouts
2028 ‡‡‡‡‡
2027 ‡‡‡‡‡
2026 0.92
—
—
—
—
2025 0.92
—
—
—
—
2024 0.88
—
—
—
—
2023 1.03
—
—
—
—
—
2022 0.76
—
—
—
—
2021 0.68
—
—
—
—
2020 0.60
—
—
—
—
2019 0.60
—
—
—
—
2018 0.73
—
—
—
2017 2.32
—
—
—
—
2016 2.12
—
—
—
—
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 267.00 590.00 1,044.00 1,553.00
Receivables 1,368.00 1,502.00 1,671.00 2,423.00
Inventory 1,142.00 1,299.00 1,733.00 3,857.00
Other — — — —
3,375.00 3,997.00 5,266.00 9,461.00
2023 2024 2025 Q'26
Payables 3,597.00 2,985.00 2,996.00 6,293.00
ST’ Debt 3,246.00 2,642.00 — 8,394.00
Other 714.00 835.00 785.00 1,604.00
8,916.00 8,087.00 8,290.00 19,739.00
in millions of $

Compound Annual Growth

10y 5y 3y
Sales ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Cash Flow ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Book Value ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡

Revenue

Mar Jun Sep Dec Year
’26 3,976.00 7,309.00 — —
—
’25 3,635.00 4,163.00 4,306.00 4,499.00
16,603.00
’24 3,468.00 3,922.00 3,891.00 4,070.00
15,351.00
’23 3,353.00 3,789.00 3,805.00 3,867.00
14,814.00
’22 3,078.00 3,554.00 3,622.00 3,803.00
14,057.00
’21 2,902.00 3,140.00 3,250.00 3,391.00
12,683.00
’20 2,613.00 2,864.00 3,020.00 3,121.00
11,618.00
in millions of $

Operating Cash Flow

Mar Jun Sep Dec Year
’26 281.00 895.00 — —
—
’25 209.00 431.00 639.00 712.00
1,991.00
’24 85.00 657.00 628.00 849.00
2,219.00
’23 71.00 381.00 580.00 297.00
1,329.00
’22 663.00 676.00 759.00 739.00
2,837.00
’21 546.00 593.00 794.00 941.00
2,874.00
’20 414.00 648.00 604.00 790.00
2,456.00
in millions of $

Free Cash Flow

Mar Jun Sep Dec Year
’26 182.00 712.00 — —
—
’25 88.00 323.00 528.00 563.00
1,502.00
’24 (104.00) 525.00 503.00 677.00
1,601.00
’23 (35.00) 291.00 459.00 142.00
857.00
’22 622.00 599.00 677.00 728.00
2,626.00
’21 446.00 492.00 657.00 946.00
2,541.00
’20 449.00 524.00 514.00 655.00
2,142.00
in millions of $

EPS

Mar Jun Sep Dec Year
’26 0.20 0.04 — —
—
’25 0.38 0.40 0.49 0.26
1.53
’24 0.33 0.38 0.45 (0.11)
1.05
’23 0.33 0.36 0.37 0.49
1.55
’22 0.41 0.15 0.13 0.32
1.01
’21 0.23 0.31 0.37 0.59
1.50
’20 0.11 0.21 0.31 0.30
0.93

Target Price Range

High
‡‡‡‡‡
‡‡‡‡
Average
‡‡‡‡‡
‡‡‡‡
Low
‡‡‡‡‡
‡‡‡‡

Recommendation Rating

1.9
1
Buy
2
3
Hold
4
5
Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 33.35 27.66 28.62 25.03 — — —
Low Price
‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 41.31 36.56 38.28 36.12 — — —
High Price
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 28,000 21,700 29,400 30,600 — — —
Employees
‡‡‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 0.50 0.68 0.52 0.54 — — —
Revenue/Emp
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 14,057.00 14,814.00 15,351.00 16,603.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 52.10% 54.54% 55.56% 54.20% — — —
Gross Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,719.00 2,757.00 1,914.00 2,687.00 ‡‡‡‡‡ — —
EBT
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 12.23% 18.61% 12.47% 16.18% ‡‡‡ ‡‡‡ ‡‡‡
EBT Margin
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,436.00 2,181.00 1,441.00 2,079.00 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Net Income
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 709.00 720.00 1,039.00 753.00 — — —
Depreciation
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 9.92 10.59 11.27 12.23 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Revenue/Sh
‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ ‡‡‡‡ 1.01 1.56 1.06 1.53 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Earnings/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.00 0.95 1.63 1.47 ‡‡‡‡ — —
Cash Flow/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (0.15) (0.34) (0.45) (0.36) ‡‡‡ ‡‡‡ ‡‡‡
Capex/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1.85 0.61 1.18 1.11 — — —
Free CF/Sh
‡‡‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 17.73 18.35 17.80 18.79 ‡‡‡‡‡ — —
Book Value/Sh
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 1,416.80 1,399.30 1,362.20 1,358.10 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shares
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 35.20 21.39 30.59 18.31 ‡‡‡‡ ‡‡‡‡ ‡‡‡‡
PE Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 3.58 3.15 2.85 2.29 ‡‡‡ ‡‡‡ ‡‡‡
PS Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.00 1.82 1.80 1.49 ‡‡‡ ‡‡‡ ‡‡‡
PB Ratio
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4.42 4.02 3.83 3.17 ‡‡‡‡ ‡‡‡ ‡‡‡‡
EV/Sales
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 23.66 69.57 36.68 35.07 — — —
EV/FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,837.00 1,329.00 2,219.00 1,991.00 ‡‡‡ ‡‡‡ ‡‡‡
Op' Cash Flow
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (211.00) (472.00) (618.00) (489.00) ‡‡‡‡‡ ‡‡‡‡‡ —
Capex
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2,626.00 857.00 1,601.00 1,502.00 ‡‡‡‡‡ — —
FCF
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ (4,272.00) (5,541.00) (4,090.00) (3,024.00) — — —
Working Cap'
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 12,299.00 13,191.00 15,554.00 13,036.00 — — —
Total Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 11,764.00 12,924.00 14,964.00 11,992.00 — — —
Net Debt
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 25,125.00 25,676.00 24,243.00 25,516.00 — — —
Sh' Equity
‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 2.80% 4.20% 2.73% 3.82% ‡‡‡‡‡ — —
ROA
‡‡‡‡‡ ‡‡‡ ‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 4.41% 5.17% 4.13% 5.96% — — —
ROIC
‡‡‡‡‡ ‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ 5.73% 8.59% 5.77% 8.36% ‡‡‡‡‡ — —
ROE
predictions in italic, sparklines do not include predictions

Analyst Commentary (Summary)

Keurig Dr Pepper (KDP) boasts impressive revenue growth—138% from $6.44 billion in 2016 to $15.35 billion in 2024, at 13% CAGR—fueled by the 2018 $19 billion merger and bolt-ons, yet shadows loom: revenue per employee plunged 24% to $522k in 2024 amid a 47% headcount surge, signaling inefficiencies. Profitability is erratic, with EBT margins halving from 22.1% in 2021 to 12.5% in 2024, EPS dropping 30% to $1.06, and FCF per share recovering modestly to $1.18 after a 67% crash. Gross margins hold steady at 52-56%, but ROE averages a lackluster 6% versus peers like Coca-Cola’s 40%.

The balance sheet raises alarms: net debt at $15 billion (97% of equity, ~5x EBITDA) in a high-rate world, ROIC at a dismal 4.1%, and insiders flooding sells (70x buys by dollar value in 2025). Stock trades near lows, with PS at 2.9x and EV/FCF at 37x—cheap historically, but decoupled from doubled revenue since 2018 amid pod sales softening and macro pressures.

Analysts project 18% upside to mean targets, EPS surging 66% to $1.76 in 2025 on margin repair and sticky brands, but contrarians flag debt squeezes, health trends eroding sodas, and insider exodus as harbingers of stalls. Far from a defensive staple, KDP’s merger glow fades—dive deeper for the full quant teardown.

Read full commentary →

Keurig Dr Pepper, Inc (KDP) Latest News

News by impact score

Fine-tune

15 Sep

4 , 8:23 AM
Bank of America analysis shows a Keurig Dr Pepper split could unlock substantial shareholder value by separating beverage and coffee businesses. Potential corporate split represents major strategic move likely to significantly alter company trajectory and investor sentiment.

14 Sep

4 www.thestreet.com, 11:33 PM
Keurig Dr Pepper is weighing a breakup that could isolate and highlight its stronger business segments. Breakup talks represent a major strategic move that can materially alter company structure and investor sentiment.

11 Sep

3 , 9:50 AM
Keurig Dr Pepper questions whether its international business can sustain double-digit sales growth. International sales growth sustainability would influence KDP revenue trajectory and market positioning but remains balanced by domestic operations.

2 Sep

4 www.just-drinks.com, 8:50 AM
Keurig Dr Pepper will sell a stake and a factory to Chobani. Divestiture of stake and factory constitutes major strategic move that alters asset base and operations.

3 www.just-food.com, 5:44 AM
Keurig Dr Pepper will sell a stake and factory to Chobani. Stake and factory sale represents a moderate strategic adjustment affecting operations.

1 Sep

3 qz.com, 1:59 PM
Keurig Dr Pepper sells its Chobani stake and Pennsylvania factory for $925 million. The $925 million divestiture boosts cash reserves and financial flexibility without altering core operations.

3 investorshub.advfn.com, 9:37 AM
Keurig Dr Pepper sells its Chobani stake and facility for $925 million. Non-core asset sale delivers $925 million cash inflow that strengthens KDP balance sheet without altering core beverage operations.

3 , 8:08 AM
Keurig Dr Pepper plans to sell its Chobani stake for $800 million and Allentown facilities for $125 million. Divestitures generate nearly one billion dollars in proceeds for potential reinvestment or debt reduction.

3 , 7:30 AM
Keurig Dr Pepper advances strategic priorities through enhanced partnership with Chobani. Enhanced Chobani partnership supports strategic priorities with moderate effects on operations and positioning.

27 Aug

3 , 4:39 PM
High coffee prices cause ground coffee sales to outperform K-Cups. K-Cup segment faces relative sales pressure amid elevated coffee costs.

21 Aug

3 , 12:21 PM
Keurig Dr Pepper faces softness in coffee markets while energy drink growth shows potential to offset revenue pressure and support overall performance. Energy growth versus coffee softness directly influences Keurig Dr Pepper financial results and competitive positioning.

14 Aug

3 , 1:12 AM
Keurig Dr Pepper launches new 7UP formula and Dr Pepper shakes while adding a board member. New product formulas and board addition represent incremental innovations with potential moderate effects on operations and positioning.

13 Aug

3 , 10:37 AM
Keurig Dr Pepper evaluates whether JDE Peet's can accelerate its growth via expanded coffee operations and market reach. JDE Peet's contribution may lift KDP coffee segment results but remains speculative without confirmed strategic shifts.

3 transcript www.fool.com, 8:13 AM
Keurig Dr Pepper reported Q2 2026 financial results and outlook during its earnings call. Quarterly earnings details provide key financial metrics that can moderately influence stock performance.

10 Aug

4 247wallst.com, 8:25 AM
Beverage giants are targeting energy drink assets for buyouts with Keurig Dr Pepper among companies circling potential targets. Energy drink buyout interest signals major strategic expansion moves that could shift Keurig Dr Pepper's competitive position.

3 , 3:25 AM
Keurig Dr Pepper Q2 results show strong refreshment beverages performance offsetting coffee margin pressures during ongoing integration. Q2 segment offsets during integration indicate moderate effects on financial performance and trajectory.

7 Aug

3 , 2:14 AM
Keurig Dr Pepper beat Q2 earnings expectations yet faces questions on whether its undervalued status is overstated. Q2 earnings beat and valuation debate create moderate short-term effects on KDP share price and sentiment.

6 Aug

4 transcript app.moby.co, 6:32 PM
Keurig Dr Pepper Inc. released its Q2 2026 earnings call summary covering financial results and outlook. Q2 earnings call details typically drive notable shifts in valuation and investor outlook for the company.

3 transcript www.marketbeat.com, 4:04 PM
Keurig Dr Pepper Q2 earnings call highlighted company financial results, operational updates, and forward guidance. Earnings call provides quarterly financial and outlook details that can moderately influence near-term stock sentiment.

3 , 12:02 PM
Keurig Dr Pepper Q2 earnings and sales beat estimates driven by JDE Peet's strength. Q2 earnings beat may lift near-term sentiment but does not signal major long-term shifts.

3 , 7:56 AM
Keurig Dr Pepper exceeded Q2 CY2026 sales expectations. Quarterly sales beats can lift near-term stock sentiment and valuation multiples without altering long-term strategy.

4 Aug

3 , 8:25 AM
Keurig Dr Pepper prepares to release Q2 earnings with investor focus on whether results will exceed expectations. Pending quarterly results can move near-term stock sentiment and highlight operational trends.

30 Jul

3 , 10:00 AM
Keurig Dr Pepper expects earnings growth, raising the question of whether investors should buy the stock. Earnings growth projections may moderately influence KDP share prices and investor decisions.

29 Jul

3 , 9:14 AM
Keurig Dr Pepper shares rise after reporting strong beverage sales. Strong sales signal improved revenue momentum but do not signal transformative shifts.

21 Jul

3 , 8:27 AM
Encouraging health news for coffee drinkers emerges that could lift consumption of Keurig Dr Pepper beverages and pods. Positive coffee health findings may modestly lift near-term demand for KDP products but are unlikely to shift company trajectory.

13 Jul

3 247wallst.com, 10:53 AM
Keurig Dr Pepper offers superior upside potential versus Coca-Cola's costly low-growth premium valuation, positioning KDP as the stronger buy for investors seeking better returns in the beverage sector. Positions KDP with stronger growth upside relative to Coca-Cola, likely influencing near-term investor sentiment without major operational shifts.

9 Jul

3 , 12:26 PM
Green Mountain Coffee Roasters offers America's greatest opportunities as a key growth area tied to Keurig Dr Pepper operations. Green Mountain Coffee Roasters opportunities may moderately influence Keurig Dr Pepper financial performance and positioning.

6 Jul

3 , 11:04 AM
Keurig Dr Pepper's innovation pipeline faces questions over its continued ability to deliver market share gains amid intensifying beverage competition. Continued innovation success directly affects Keurig Dr Pepper's ability to sustain share gains versus rivals.

4 Jul

4 , 2:08 PM
Keurig Dr Pepper reshuffles leadership as plans to split into two companies advance. Leadership reshuffle tied to company split represents major strategic move likely to alter trajectory and investor sentiment.

1 Jul

4 www.barchart.com, 7:26 AM
Keurig Dr Pepper prepares to release quarterly earnings with focus on revenue trends, margins, and forward guidance amid consumer beverage market shifts. Upcoming earnings results and guidance directly shape near-term stock moves and valuation for Keurig Dr Pepper.
© 2016–2026 stockrow.com Terms and Conditions Indicators Contact Us